Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I

Journal of Neuroscience

Volumn 22, Issue 2, 2002, Pages 404-412

  Pedersen, Ward A ^a,b   Wan, Ruiqian ^a   Zhang, Peisu ^a   Mattson, Mark P ^a,c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antalarmin; CAMP; Excitotoxicity; Lipid peroxidation; Sauvagine; Stress

Indexed keywords

4 HYDROXYNONENAL; AMYLOID BETA PROTEIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; FERROUS SULFATE; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE; PROTEIN KINASE C; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN II;

ALZHEIMER DISEASE; ANIMAL CELL; ANXIETY NEUROSIS; ARTICLE; BINDING AFFINITY; BRAIN ISCHEMIA; BRAIN REGION; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; NERVE CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRESS;

EID: 0037079998     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-02-00404.2002     Document Type: Article

References (71)

1. s-induced neurodegeneration in Caenorhabditis elegans
2. Cellular localization of corticotropin-releasing factor receptors in the adult mouse cerebellum
3. Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors
4. CRH-like peptides protect cardiac myocytes from lethal ischaemic injury
5. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway
6. Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons
7. Corticotropin-releasing hormone stimulates P450 17α-hydroxylase/17,20-lyase in human fetal adrenal cells via protein kinase C
8. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain
9. 1 receptor antagonist
10. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
11. Influence of corticotropin-releasing factor on neuronal cell death in vitro and in vivo
12. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry, and role in central nervous system and immune disorders
13. Pathobiology of ischaemic stroke: An integrated view
14. A synthetic inhibitor of the mitogen-activated protein kinase cascade
15. Concomitant changes in CRH mRNA levels in rat hippocampus and hypothalamus following immobilization stress
16. q-proteins
17. Rat cerebral cortex corticotropin-releasing hormone receptors: Evidence for receptor coupling to multiple G-proteins
18. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease
19. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
20. The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells
21. 125I-antisauvagine-30: A novel, specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors
22. sα-selective G-protein antagonists
23. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor
24. Activation of mGluRII induces LTD via activation of protein kinase A and protein kinase C in the dentate gyrus of the hippocampus in vitro
25. Neuropathology of Alzheimer's disease: A critical update
26. Cyclic nucleotides attenuate lipid peroxidation-mediated neuron toxicity
27. Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
28. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
29. Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat
30. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF-2 receptor
31. Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid β precursor protein and with suppression of nuclear factor-κB
32. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates
33. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
34. The role of excitotoxicity in ALS - What is the evidence?
35. Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure
36. 3 in corticotropin-releasing hormone-induced cell shape changes in invertebrate immunocytes
37. Synaptic plasticity and memory: An evaluation of the hypothesis
38. Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives
39. Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity
40. Neurotrophic factors and the aging brain
41. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
42. Stress and hippocampal plasticity
43. Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression
44. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain
45. Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity
46. Expression and protective effects of urocortin in cardiac myocytes
47. Excitotoxic neurodegeneration in Alzheimer disease
48. 2+-and protein kinase C-dependent amylase release in permeabilized rat pancreatic acini
49. Inhibition of the cAMP pathway decreases early long-term potentiation at CA1 hippocampal synapses
50. Unilateral amnesic stroke. Six new cases and a review of the literature
51. Physiology and pharmacology of corticotropin-releasing factor
52. Protein kinase A activity is required for depolarization-induced proline-rich tyrosine kinase 2 and mitogen-activated protein kinase activation in PC12 cells
53. The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis
54. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease
55. Corticotropin-releasing factor receptors and their ligand family
56. Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor
57. Increased corticotropin-releasing factor immunoreactivity in select brain sites following kainate-elicited seizures
58. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation
59. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2
60. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors
61. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2β-selective antisauvagine-30
62. Chemistry and biochemistry of oxidative stress in neurodegenerative disease
63. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes
64. Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
65. Corticotropin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischemia or activation of NMDA receptors
66. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
67. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse
68. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation
69. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH
70. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency
71. Focal cerebral ischemia induces CRH mRNA in rat cerebral cortex and amygdala